Spirit Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Spirit Pharmaceuticals Ownership

Who owns Spirit Pharmaceuticals?

Spirit Pharmaceuticals is owned by Leedon Park Capital, NewSpring Capital and Tecum Capital. It was acquired on April 27, 2021.

Is Spirit Pharmaceuticals PE-backed?

Yes. Spirit Pharmaceuticals is owned by private equity investors Leedon Park Capital, NewSpring Capital and Tecum Capital.

Spirit Pharmaceuticals Business Overview

Where is Spirit Pharmaceuticals headquartered?

Spirit Pharmaceuticals is headquartered in Ronkonkoma, New York.

What sector is Spirit Pharmaceuticals in?

Spirit Pharmaceuticals is a life science company.

When was Spirit Pharmaceuticals founded?

Spirit Pharmaceuticals was founded in 2003.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 395 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 349 by strategics.

Spirit Pharmaceuticals

Spirit Pharmaceuticals LLC

2004-02 Orville Dr N,
Ronkonkoma, New York 11779
United States,
(215) 943-4000
www.spiritpharma.com

Spirit Pharmaceuticals innovates, develops, packages, and distributes private-label, over-the-counter pharmaceutical products. Spirit Pharmaceuticals was founded in 2003 and is based in Ronkonkoma, New York.


 Subscribe to unlock this and 207,877
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.